CTS maintaied prior full-year guidance of 6 to
8% sales growth.
For the quarter capital expenditures were $3.4 million, or 2% of sales, and free cash flow was $11.4 million. The full-year capital expenditures are expected to be $18 million to $20 million. Free cash flow was $20,000 in the first quarter, and $10.8 million in the second quarter last year.
The new Czech Republic facility of CTS began operations during the quarter. Production will be increased gradually throughout the year to meet business growth and better serve automotive OEMs in that region.
EMS sales were $94.2 million, up $2.4 million year-on-year and $11.3 million sequentially. Operating income from EMS operations were $2.5 million.